Audit of overall treatment time in chemoradiation for cervical carcinoma

被引:0
|
作者
King, M [1 ]
Fernando, I [1 ]
机构
[1] Queen Elizabeth Hosp, Birmingham B15 2TH, W Midlands, England
关键词
D O I
10.1016/j.clon.2003.07.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:80 / 80
页数:1
相关论文
共 50 条
  • [31] The effects of treatment duration on outcomes of radiation treatment with high-dose-rate brachytherapy in the era of concurrent chemoradiation for cervical carcinoma
    Chen, T. W.
    Wandrey, N. E.
    Ha, C. S.
    Eng, Tony Y.
    JOURNAL OF RADIATION ONCOLOGY, 2018, 7 (03) : 265 - 274
  • [32] The impact of overall treatment time on the results of radiotherapy for nonsmall cell lung carcinoma
    Koukourakis, M
    Hlouverakis, G
    Kosma, L
    Skarlatos, J
    Damilakis, J
    Giatromanolaki, A
    Yannakakis, D
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1996, 34 (02): : 315 - 322
  • [33] Clinical significance of cumulative biological effective dose and overall treatment time in the treatment of carcinoma cervix
    Mandal, Abhijit
    Asthana, Anupam Kumar
    Aggarwal, Lalit Mohon
    JOURNAL OF MEDICAL PHYSICS, 2007, 32 (02) : 68 - 72
  • [34] Neoadjuvant chemotherapy, radical hysterectomy and chemoradiation for stage iva cervical carcinoma
    Micha, John P.
    Epstein, Howard D.
    Roossin, Michael C.
    Bohart, Randy
    Rettenmaier, Mark A.
    Goldstein, Bram H.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (05) : 797 - 801
  • [35] Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana
    MacDuffie, Emily
    Bvochora-Nsingo, Memory
    Chiyapo, Sebathu
    Balang, Dawn
    Chambers, Allison
    George, Jessica M.
    Tuli, Shawna
    Lin, Lilie L.
    Zetola, Nicola M.
    Ramogola-Masire, Doreen
    Grover, Surbhi
    INFECTIOUS AGENTS AND CANCER, 2021, 16 (01)
  • [36] Is There a Role for Adjuvant Hysterectomy after Suboptimal Concurrent Chemoradiation in Cervical Carcinoma?
    Walji, N.
    Chue, A. L.
    Yap, C.
    Rogers, L. J.
    El-Modir, A.
    Chan, K. K.
    Singh, K.
    Fernando, I. N.
    CLINICAL ONCOLOGY, 2010, 22 (02) : 140 - 146
  • [37] Radiobiological Effectiness and Side Effects of Chemoradiation and Brachitherapy in Advanced Cervical Carcinoma
    Montemaggi, P.
    Federico, M.
    Rizzo, S.
    Bronte, G.
    Guerrieri, P.
    Cucchiara, T.
    Russo, A.
    Agostara, B.
    ONCOLOGY, 2009, 77 : 152 - 152
  • [38] Five-year overall survival following chemoradiation therapy for locally advanced cervical carcinoma in women living with and without HIV infection in Botswana
    Emily MacDuffie
    Memory Bvochora-Nsingo
    Sebathu Chiyapo
    Dawn Balang
    Allison Chambers
    Jessica M. George
    Shawna Tuli
    Lilie L. Lin
    Nicola M. Zetola
    Doreen Ramogola-Masire
    Surbhi Grover
    Infectious Agents and Cancer, 16
  • [39] Development and validation of yoga therapy module for cervical carcinoma undergoing chemoradiation
    Nelson, N. K.
    Govardhan, H. B.
    Khaleel, I.
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] RADIOBIOLOGICAL EFFECTINESS AND SIDE EFFECTS OF CHEMORADIATION AND BRACHITHERAPY IN ADVANCED CERVICAL CARCINOMA
    Moscadini, L.
    Guerrieri, P.
    Daidone, A.
    Mangiapane, M.
    Diana, G.
    Sciume, F.
    Evangelista, G.
    Ferrera, G.
    Montemaggi, P.
    RADIOTHERAPY AND ONCOLOGY, 2009, 91 : S39 - S39